I guess this means a further delay of PTX-100. While obviously great for the patients - and the efficacy of the drug - it is a bit annoying that the trial has been delayed because they don't have enough supply of PTX-100.
"In another positive sign, a number of patients in the trial remained on the therapy longer than anticipated, necessitating a new manufacturing run to meet demand. Patient enrolment at the current cohort will need to be managed in line with available drug supply until the new manufacturing run is completed and made available."
This part was also interesting. Clearly of interest is what "partnership relationships" and corporate transactions" means.
Principal activities During the financial half-year the principal continuing activities of the consolidated entity consisted of:
● the preparation for and conduct of research and development of the Company's proprietary technologies and products;
● business development associated with the promotion of Prescient's proprietary technologies and products; and
● business development associated with developing collaborative, partnership relationships and corporate transactions.
PTX Price at posting:
10.5¢ Sentiment: Hold Disclosure: Held
